Santiago Castera, Sr.

Biochemist, Ms.
Departamento de Hemostasia y Trombosis. Academia Nacional de Medicina
CABA, Ciudad Autonoma de Buenos Aires, Argentina

Presentation(s):

• PB0359 - Atypical type 2B von Willebrand disease (VWD2B): key role of ristocetin-induced platelet aggregation at lower doses (RIPA-LD) to guide diagnosis. A single-center experience.

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0310 - Exploring the behavior of ADAMTS13/VWF parameters and their roles in the PathologicalMechanisms involved in Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP).

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0292 - Latin-American von Willebrand Disease Registry (RL-VWD): registration of congenital and acquired VWD patients in Latin-America; a randomized controlled trial. Preliminary results.

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0282 - Probable additive effect of SNVs on the phenotype of VWD2N patients with p.R816W

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0291 - VWD2M-C: A fugitive diagnosis. About a case.

  Sunday, June 23, 2024
  13:45 – 14:45 ICT